RxDoctor Payments DataLook up a doctor →

CAPLYTA: payments to doctors

Payments that named CAPLYTA as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$50.2M
Providers
72,636
Transactions
622,180
Average per transaction
$81

The per-transaction average — $81 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 72,636 providers the average total is $692, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$27,717,00155.2%
ITI, Inc.$22,521,76944.8%
Johnson & Johnson$1670.0%
← All drugs & devices